GV20 Trademark

Trademark Overview


On Thursday, August 26, 2021, a trademark application was filed for GV20 with the United States Patent and Trademark Office. The USPTO has given the GV20 trademark a serial number of 90903700. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Saturday, January 25, 2025. This trademark is owned by GV20 Therapeutics LLC. The GV20 trademark is filed in the Computer & Software Services & Scientific Services category with the following description:

Conducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services;software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development
gv20

General Information


Serial Number90903700
Word MarkGV20
Filing DateThursday, August 26, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateSaturday, January 25, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, January 3, 2023

Trademark Statements


Pseudo MarkGV TWO ZERO; GV TWENTY
Goods and ServicesConducting early evaluations in the field of new pharmaceuticals; research and development of pharmaceutical and biopharmaceutical preparations and medicines; Pharmaceutical and biotechnology products development; Research and development in the pharmaceutical and biotechnology fields; pharmaceutical and biopharmaceutical research services in the fields of cancer and genetic diseases; pharmaceutical and biopharmaceutical research services in the nature of biomarker identification; pharmaceutical and biopharmaceutical research services, namely, artificial intelligence assisted drug discovery and development services;software as a service (SAAS) services featuring artificial intelligence software for drug discovery and development

Classification Information


International Class042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateWednesday, October 13, 2021
Primary Code042
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameGV20 Therapeutics LLC
Party Type20 - Owner at Publication
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02139

Party NameGV20 Therapeutics LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressCambridge, MA 02142

Trademark Events


Event DateEvent Description
Monday, August 30, 2021NEW APPLICATION ENTERED
Tuesday, November 29, 2022EXAMINERS AMENDMENT -WRITTEN
Tuesday, November 29, 2022EXAMINERS AMENDMENT E-MAILED
Tuesday, November 29, 2022NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Wednesday, November 30, 2022ASSIGNED TO LIE
Wednesday, November 30, 2022EXAMINER'S AMENDMENT ENTERED
Thursday, December 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 13, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, June 1, 2022ASSIGNED TO EXAMINER
Monday, June 6, 2022NON-FINAL ACTION WRITTEN
Monday, June 6, 2022NON-FINAL ACTION E-MAILED
Monday, June 6, 2022NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, February 28, 2023NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, August 24, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, December 14, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, January 3, 2023PUBLISHED FOR OPPOSITION
Tuesday, January 3, 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Thursday, August 24, 2023SOU EXTENSION 1 GRANTED
Thursday, August 24, 2023SOU EXTENSION 1 FILED
Friday, September 22, 2023TEAS CHANGE OF OWNER ADDRESS RECEIVED
Monday, January 29, 2024SOU EXTENSION 2 FILED
Monday, January 29, 2024SOU EXTENSION 2 GRANTED
Wednesday, January 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU TEAS EXTENSION RECEIVED
Saturday, August 26, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, September 22, 2023APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Friday, September 22, 2023TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, January 29, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 31, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 31, 2024SOU EXTENSION 3 GRANTED
Wednesday, July 31, 2024SOU EXTENSION 3 FILED
Friday, January 24, 2025SOU TEAS EXTENSION RECEIVED
Saturday, January 25, 2025SOU EXTENSION 4 FILED
Saturday, January 25, 2025SOU EXTENSION 4 GRANTED
Tuesday, July 29, 2025SOU TEAS EXTENSION RECEIVED
Tuesday, March 4, 2025NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED